CD40L monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD40L monoclonal antibody, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D) [Phase 1, Phase 2]